Best Peptides for Energy & Vitality: MOTS-c, NAD+ & More

The feeling of "having less energy" that accompanies ageing has concrete biological underpinnings. At the cellular level, energy production depends on mitochondria — the organelles that convert nutrients into ATP (adenosine triphosphate), the universal energy currency of cells.

Several factors contribute to age-related energy decline:

• •Mitochondrial dysfunction: Mitochondria accumulate DNA mutations and oxidative damage over time, reducing their efficiency. By age 70, mitochondrial function may decline by 30–50% compared to age 20.
• •NAD+ depletion: NAD+ is a critical coenzyme for mitochondrial energy production. Levels decline approximately 50% between ages 40 and 60.
• •Hormonal changes: Growth hormone, testosterone, thyroid hormones, and DHEA all decline with age, reducing metabolic rate and energy availability.
• •Increased inflammation: Chronic low-grade inflammation ("inflammaging") diverts metabolic resources from productive energy generation.
• •Reduced muscle mass: Sarcopenia (age-related muscle loss) reduces the body's metabolic capacity.

Peptide-based approaches to energy restoration target these mechanisms at the cellular and hormonal levels, potentially addressing root causes rather than providing stimulant-like symptomatic relief.

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded by mitochondrial DNA. It was discovered in 2015 by Professor Pinchas Cohen's lab at USC and has rapidly become one of the most exciting peptides in metabolic and ageing research.

Key Mechanisms: - Activates AMPK (AMP-activated protein kinase), the master metabolic sensor that responds to energy stress - Increases glucose uptake in skeletal muscle independently of insulin - Promotes fatty acid oxidation, improving the body's ability to use fat for fuel - Regulates the folate cycle and methionine metabolism, connecting to epigenetic regulation - Translocates to the nucleus during metabolic stress, directly regulating gene expression

Why It's Called an Exercise Mimetic: MOTS-c levels increase during physical exercise, and its cellular effects overlap significantly with the metabolic benefits of exercise — improved insulin sensitivity, enhanced fatty acid oxidation, increased glucose utilisation, and AMPK activation. This has led researchers to investigate whether MOTS-c supplementation could provide some exercise-like metabolic benefits.

Research Highlights: - Prevented age-related insulin resistance in mice - Improved exercise capacity in aged mice - Currently in human clinical trials for metabolic applications - Levels decline with age, correlating with metabolic deterioration - May serve as both a biomarker and therapeutic target for metabolic ageing

NAD+ (nicotinamide adenine dinucleotide) sits at the intersection of virtually every major metabolic pathway. It serves as a coenzyme in mitochondrial energy production, activates sirtuin enzymes (which regulate DNA repair and inflammation), and is required for over 500 enzymatic reactions.

Why NAD+ Matters for Energy: Without adequate NAD+, mitochondria cannot efficiently convert nutrients into ATP. The age-related decline in NAD+ is now considered a key driver of metabolic dysfunction, reduced exercise capacity, and the subjective experience of "less energy."

Restoration Strategies: - NMN (Nicotinamide Mononucleotide): A direct precursor to NAD+ that has shown promise in restoring NAD+ levels. Human trials show increases in blood NAD+ levels and improvements in physical performance markers. - NR (Nicotinamide Riboside): Another NAD+ precursor with clinical evidence of safely elevating NAD+ levels. - CD38 inhibitors: CD38 is an enzyme that degrades NAD+. Its activity increases with age and inflammation. Inhibiting CD38 may preserve existing NAD+ levels.

Connection to Peptide Biology: NAD+-dependent sirtuins regulate many of the same pathways targeted by anti-ageing peptides. Restoring NAD+ may amplify the effects of other interventions by ensuring the cellular machinery has adequate coenzyme supply.

Clinical Evidence: A 2024 NMN trial in middle-aged adults showed improved walking speed and grip strength after 12 weeks. Multiple trials demonstrate safe elevation of blood NAD+ metabolites. Long-term outcome data is still accumulating.

Growth hormone (GH) plays a significant role in energy metabolism, body composition, and subjective vitality. GH-deficient adults consistently report fatigue, reduced exercise capacity, and impaired quality of life — symptoms that resolve with GH replacement therapy.

CJC-1295: A GHRH analogue that stimulates pulsatile GH release from the pituitary. When modified with Drug Affinity Complex (DAC), it has an extended half-life allowing less frequent dosing. CJC-1295 increases GH and IGF-1 levels, which support fat oxidation, lean body mass maintenance, and energy availability.

Ipamorelin: A selective GH secretagogue that triggers GH release through the ghrelin receptor without significantly affecting cortisol or prolactin. Its selectivity makes it well-suited for protocols focused on recovery and energy rather than appetite stimulation.

How GH Affects Energy: - Promotes lipolysis (fat breakdown), making stored energy available - Supports lean muscle mass, increasing metabolic capacity - Improves sleep quality (particularly deep sleep), enhancing overnight recovery - Supports immune function, reducing the metabolic burden of chronic inflammation - Maintains bone density and connective tissue health

SS-31 (Elamipretide): This mitochondria-targeted tetrapeptide stabilises the inner mitochondrial membrane by binding cardiolipin, directly improving electron transport chain efficiency. It's currently in clinical trials for mitochondrial myopathy and heart failure, representing a direct pharmacological approach to mitochondrial energy restoration.

Disclaimer: This article is for educational purposes only. It is not medical advice. Persistent fatigue should be evaluated by a healthcare professional to rule out medical conditions. Consult your doctor before considering any peptide research protocols.